115 related articles for article (PubMed ID: 33389051)
21. Tumor dose enhancement by nanoparticles during high dose rate (192)Ir brachytherapy.
Zabihzadeh M; Arefian S
J Cancer Res Ther; 2015; 11(4):752-9. PubMed ID: 26881513
[TBL] [Abstract][Full Text] [Related]
22. Dose characterization in the near-source region for two high dose rate brachytherapy sources.
Wang R; Li XA
Med Phys; 2002 Aug; 29(8):1678-86. PubMed ID: 12201413
[TBL] [Abstract][Full Text] [Related]
23. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
[TBL] [Abstract][Full Text] [Related]
24. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
[TBL] [Abstract][Full Text] [Related]
25. Dosimetry parameters of the IRH10 192Ir high dose rate brachytherapy source.
Yi CY; Chun KJ; Hah SH; Kim HM; Lim C
J Radiat Res; 2010; 51(4):485-92. PubMed ID: 20508393
[TBL] [Abstract][Full Text] [Related]
26. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source.
Karaiskos P; Angelopoulos A; Pantelis E; Papagiannis P; Sakelliou L; Kouwenhoven E; Baltas D
Med Phys; 2003 Jan; 30(1):9-16. PubMed ID: 12557972
[TBL] [Abstract][Full Text] [Related]
27. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
[TBL] [Abstract][Full Text] [Related]
28. Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment.
Saini AS; Zhang GG; Finkelstein SE; Biagioli MC
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1263-7. PubMed ID: 20950949
[TBL] [Abstract][Full Text] [Related]
29. Correction factors for source strength determination in HDR brachytherapy using the in-phantom method.
Ubrich F; Wulff J; Engenhart-Cabillic R; Zink K
Z Med Phys; 2014 May; 24(2):138-52. PubMed ID: 24021956
[TBL] [Abstract][Full Text] [Related]
30. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
[TBL] [Abstract][Full Text] [Related]
31. Monte Carlo dosimetry of the microselectron HDR 192Ir brachytherapy source using MCNP4A.
Wallace S; Wong T; Fernando W
Australas Phys Eng Sci Med; 1998 Mar; 21(1):11-7. PubMed ID: 9633148
[TBL] [Abstract][Full Text] [Related]
32. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
[TBL] [Abstract][Full Text] [Related]
33. Monte Carlo study of the dose rate distributions for the Ir2.A85-2 and Ir2.A85-1 Ir-192 afterloading sources.
Granero D; Pérez-Calatayud J; Ballester F
Med Phys; 2008 Apr; 35(4):1280-7. PubMed ID: 18491521
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
[TBL] [Abstract][Full Text] [Related]
35. Monte Carlo dosimetry of the IRAsource high dose rate (192)Ir brachytherapy source.
Sarabiasl A; Ayoobian N; Jabbari I; Poorbaygi H; Javanshir MR
Australas Phys Eng Sci Med; 2016 Jun; 39(2):413-22. PubMed ID: 26906341
[TBL] [Abstract][Full Text] [Related]
36. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
37. TLD, diode and Monte Carlo dosimetry of an 192Ir source for high dose-rate brachytherapy.
Kirov As; Williamson JF; Meigooni AS; Zhu Y
Phys Med Biol; 1995 Dec; 40(12):2015-36. PubMed ID: 8719942
[TBL] [Abstract][Full Text] [Related]
38. Dose distributions of an ¹⁹²Ir brachytherapy source in different media.
Wu CH; Liao YJ; Liu YW; Hung SK; Lee MS; Hsu SM
Biomed Res Int; 2014; 2014():946213. PubMed ID: 24804263
[TBL] [Abstract][Full Text] [Related]
39. Air-kerma strength determination of an HDR
Smith BR; Micka JA; Aima M; DeWerd LA; Culberson WS
Med Phys; 2017 Jan; 44(1):311-320. PubMed ID: 28102953
[TBL] [Abstract][Full Text] [Related]
40. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
